Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3 Paraskevis, 2020, Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event, Infect Genet Evol, 79, 10.1016/j.meegid.2020.104212 Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 10.1016/S0140-6736(20)30251-8 Brian, 2005, Coronavirus genome structure and replication, Curr Top Microbiol Immunol, 287 Yang, 2006, Drug design targeting the main protease, the Achilles’ heel of coronaviruses, Curr Pharm Des, 12, 4573, 10.2174/138161206779010369 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 10.1016/S0140-6736(20)30183-5 Xu, 2004, Epidemiologic clues to SARS origin in China, Emerg Infect Dis, 10, 10.3201/eid1006.030852 de Groot, 2013, Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group, J Virol, 87, 7790, 10.1128/JVI.01244-13 Chan, 2020, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 395, 10.1016/S0140-6736(20)30154-9 Anand, 2003, Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs, Science, 300, 1763, 10.1126/science.1085658 Hilgenfeld, 2014, From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design, FEBS J, 281, 10.1111/febs.12936 Gentile, 2020, Putative inhibitors of SARS-COV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study, Mar Drugs, 18, 10.3390/md18040225 Jin, 2020, Structure of M pro from COVID-19 virus and discovery of its inhibitors, Nature, 10.1038/s41586-020-2223-y Chang, 2020, Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking, Preprints, 1 Zhang, 2020, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors, Science, 368, 409, 10.1126/science.abb3405 Ahmed, 2020, Identifying novel inhibitor of quorum sensing transcriptional regulator (SdiA) of Klebsiella pneumoniae through modelling, docking and molecular dynamics simulation, J Biomol Struct Dyn, 1 Zeng, 2019, Investigation on the binding of aloe-emodin with tyrosinase by spectral analysis and molecular docking, Spectrochim Acta A: Mol Biomol Spectrosc, 211, 79, 10.1016/j.saa.2018.11.045 Rehman, 2016, Interaction of meropenem with ‘N’ and ‘B’ isoforms of human serum albumin: a spectroscopic and molecular docking study, J Biomol Struct Dyn, 34, 1849, 10.1080/07391102.2015.1094411 Harder, 2016, OPLS3: a force field providing broad coverage of drug-like small molecules and proteins, J Chem Theory Comput, 12, 10.1021/acs.jctc.5b00864 Li, 2011, The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling, Proteins Struct Funct Bioinform, 79, 10.1002/prot.23106 Genheden, 2015, The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities, Expert Opin Drug Discov, 10, 449, 10.1517/17460441.2015.1032936 Brańka, 2000, Nosé-Hoover chain method for nonequilibrium molecular dynamics simulation, Phys Rev E: Stat Phys Plasmas Fluids Relat Interdiscip Top, 61, 4769, 10.1103/PhysRevE.61.4769 Martyna, 1994, Constant pressure molecular dynamics algorithms, J Chem Phys, 101, 4177, 10.1063/1.467468 Khaerunnisa, 2020, Potential inhibitor of COVID-19 main protease (M pro) from several medicinal plant compounds by molecular docking study, Preprints, 1 Adem, 2020, Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA, Preprints Ahmad, 2014, Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis, J Infect Public Health, 7, 75, 10.1016/j.jiph.2013.09.001 Caminero, 2010, Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis, Lancet Infect Dis, 10, 621, 10.1016/S1473-3099(10)70139-0 Lambert, 2012, Antibiotics that affect the ribosome, Rev Sci Tech, 31, 57, 10.20506/rst.31.1.2095 Zhang, 2014, Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice, Biochem Pharmacol, 91, 74, 10.1016/j.bcp.2014.07.002 Turner, 2004, Treatment of the common cold with troxerutin, APMIS, 112, 605, 10.1111/j.1600-0463.2004.apm1120908.x Adam, 2005, Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin, Phytomedicine, 12, 52, 10.1016/j.phymed.2004.01.007 Maurya, 2005, Protection of cellular DNA from γ-radiation-induced damages and enhancement in DNA repair by troxerutin, Mol Cell Biochem, 280, 57, 10.1007/s11010-005-8052-3 Kim, 2005, Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease, Pharm Res, 22, 1499, 10.1007/s11095-005-6250-z Cohen, 2018, New activities for old antibiotics, Nat Microbiol, 3, 531, 10.1038/s41564-018-0152-4 Gopinath, 2018, Topical application of aminoglycoside antibiotics enhances host resistance to viral infections in a microbiota-independent manner, Nat Microbiol, 3, 611, 10.1038/s41564-018-0138-2